Nuclear magnetic resonance –based co-magnetometers are essential tools for applications ranging from inertial navigation to ...

Nektar Therapeutics is rated Strong Buy based on promising Phase 2b maintenance data for REZPEG in atopic dermatitis. Click ...

CNW/ - ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical ...

The EFC2400 leverages nearly a decade of our experience in customer‑specific natural refrigerant systems and packages ...

A nanophotonic diffractive network performs morphological image processing, including dilation and erosion, purely through light propagation.

Delve into the details of vertical power delivery and how it surmounts the limits of traditional lateral power when it comes to supporting secondary power rails.

Proceeds expected to fund global ENIGMA-TRS studies and extend cash runway beyond pivotal 12-week results, supporting development of evenamide as the potential first add-on therapy for ...

Agency Feedback Provides Regulatory Clarity on Enrichment Strategy and Confirms CDR-SB as Sole Primary Endpoint for Registrational ...

Newron secures up to EUR 38 million to advance its ENIGMA-TRS pivotal phase III programme: Milan, Italy Wednesday, February 18, 2026, 18:00 Hrs [IST] Newron Pharmaceuticals SpA, a ...

In Alzheimer’s disease, BioVie has conducted both Phase 2 and Phase 3 trials. Early results suggest improvements in cognition and biomarkers, supporting further trials to evaluate its potential as a ...

DoD-Funded Study Accelerates Novel PTSD Mechanism into Trials; Proven Alcohol Safety Profile De-Risks Program for ...